11/22/2022 8:34:10 AM
Teva Says Finalizes Nationwide Opioid Settlement Terms
11/21/2022 7:03:54 AM
Teva Appoints Richard Francis As President And CEO, Effective January 1, 2023
11/3/2022 7:13:40 AM
Teva Pharmaceutical Industries Limited (TEVA) Has Lowered Its FY22 Revenue Estimate To $14.8 - $15.4 Bln From $15.0 - $15.6 Bln
11/3/2022 7:05:29 AM
Teva Q3 GAAP EPS $0.05; Non-GAAP EPS $0.59
10/18/2022 8:06:48 AM
Teva Announces Positive Results From 3-Year Study Of AUSTEDO Tablets In Chorea Associated With Huntington's Disease
10/7/2022 8:34:16 AM
Teva Reaches Agreement With Attorney General Of Arkansas
to Settle State's Price-fixing Claims
9/30/2022 8:07:09 AM
Teva Reaches Agreement With Georgia To Settle The State's Price Fixing Claims
9/8/2022 1:50:38 AM
Teva Says Studies Show Effectiveness Of AJOVY For Treatment Of Migraine In Patients With Co-morbid Depression
8/29/2022 2:04:15 AM
Teva : EC Grants Marketing Authorization For Ranivisio, Biosimilar To Lucentis, For Age-related Macular Degeneration